THE EFFECT OF SUPPRESSIVE ORAL ACYCLOVIR ON THE PSYCHOLOGICAL MORBIDITY ASSOCIATED WITH RECURRENT GENITAL HERPES

Citation
O. Carney et al., THE EFFECT OF SUPPRESSIVE ORAL ACYCLOVIR ON THE PSYCHOLOGICAL MORBIDITY ASSOCIATED WITH RECURRENT GENITAL HERPES, Genitourinary medicine, 69(6), 1993, pp. 457-459
Citations number
21
Categorie Soggetti
Urology & Nephrology","Public, Environmental & Occupation Heath","Dermatology & Venereal Diseases
Journal title
ISSN journal
02664348
Volume
69
Issue
6
Year of publication
1993
Pages
457 - 459
Database
ISI
SICI code
0266-4348(1993)69:6<457:TEOSOA>2.0.ZU;2-W
Abstract
Objectives-To assess the psychological impact of recurrent genital her pes and to determine if longterm acyclovir has any impact on this morb idity. Setting and subjects-Patients with frequently recurring genital herpes attending a department of genitourinary medicine who were cons idered suitable for longterm acyclovir. Methods-Patients completed an 80 item, self-administered psychological questionnaire before starting acyclovir and every three months for one year. Treatment was then sto pped and three months later a further questionnaire was completed. The questionnaire consisted of the General Health Questionnaire (GHQ); th e Hospital Anxiety and Depression Questionnaire (HADQ); Illness Attitu de Scales and Illness Concern. Data were analysed by McNemar's test fo r changes in proportions and by Wilcoxon's test for changes in scores. Results-102 patients were recruited: 55 men, and 47 women. Eighty two (80%) patients completed three months treatment, 75 (74%) six months, 64 (63%) nine months and 61 (60%) a year. Fifty (49%) of the original 102 patients completed the three months post treatment follow up. At first visit 63% (64/102) were designated as GHQ ''cases''. Within thre e months this decreased to 26% (21/82). McNemar's test showed that 67% (34151) of the patients who were initially classified as GHQ ''cases' ' became ''noncases'' after three months (p < 0.0001). There was a sig nificant decrease in the proportion of HAD anxiety cases from visit on e to visit two (p < 0.0001) and a decrease in illness concern scores f rom visit one to visit two (p < 0.0001). All these decreases were main tained throughout the years treatment with acyclovir. Conclusions-Ther e is a substantial morbidity associated with frequently recurring geni tal herpes. However, acyclovir suppression significantly reduces illne ss concern and anxiety and is a useful addition to the treatment of th is infection.